disease-specific mechanisms by which apoE may modulate susceptibility of developing Alzheimer's disease, there has been an increasing focus on its role in modulating the CNS response to acute injury. Although the neurobiology of apoE in the injured brain remains incompletely defined, there is evi dence to suggest neurotrophic, immunomodulatory, ;:tnp anti oxidant effects. Key Words: Apolipoprotein E-Stroke Transgenic mice-Cerebral injury. volved in neural injury or repair (Aamar et al., 1992; Stoll et al., 1989; Ignatius et al., 1986; Stoll and Mueller, 1986; Snipes et al., 1986; Muller et al., 1985) .
APOLIPOPROTEIN E AND ALZHEIMER'S DISEASE
The brain provides the largest extrahepatic source of apoE synthesis, and interest in the role of apoE in the CNS was renewed after the observation that the E4 iso form is associated with increased risk of developing spo radic and late-onset familial Alzheimer's disease (Strit tmatter et al., 1993a; Saunders et a1., 1993) . The mecha nism by which apoE influences susceptibility of developing Alzheimer's disease remains to be eluci dated. An active area of investigation focuses on the hypothesis that one of the normal functions of apoE within neurons is to contribute to microtubular integrity and stabilization of the neuronal cytoskeleton. In Alzhei mer's disease, it is suggested that the widespread neuro nal disruption is a consequence of disruption of this nor mal apoE function (Roses et a1., 1995) . In support of this hypothesis, several reports have documented isoform specific interactions between apoE and the microtubule binding protein tau (Fleming et al., 1996; Strittmatter et a1., 1994) Isoform-specific interactions also have been observed between apoE and l3-amyloid, raising specula tion that apoE might influence amyloid depositioQ, me-tabolism, or fibrillogenesis (Gallo et a!., 1994; Strittmatter et a!., 1993) . The hypothesis that apoE is involved in the early stages of amyloid deposi tion is supported by our observations that most amyloid deposits after head injury are Af342(43)-positive and im munostain with apoE (Horsburgh et a!., 1997b) . The presence of the APOE4 allele also has been associated with deposition of f3 amyloid after head injury (Nicoll, 1995) .
APOLIPOPROTEIN E AND RECOVERY AFTER CNS INJURY
In addition to its association with Alzheimer's disease, several clinical observations suggest an isoform-specific role for apoE in determining outcome after acute CNS injury. In 1995, Nicoll and associates reported a neuro pathologic study on a series of patients who died within 30 days after severe head injury. The authors found that the frequency of the APOE4 allele was significantly higher in individuals with amyloid deposition than in those without. However, the mean age of the group with amyloid deposition (high APOE4 allele frequency) was 52 years, whereas that of the other group (control APOE4 frequency) was 28 years. The initial interpreta tion of this study was that the APOE4 allele was asso ciated with deposition of amyloid after head injury. However, an alternate explanation for these findings is that plaques form at a young age in people possessing the APOE4 allele, and that people with APOE4 are more likely to die after CNS trauma. This study provides in direct evidence that apoE genotype affects recovery after closed head injury (Nicoll et aI., 1995) . Direct evidence that apoE genotype influences outcome after head injury has been provided from a prospective study of 90 indi viduals studied 6 months after sustaining a head injury. Individuals possessing an APOE4 allele were found to be twice as likely to have a poor outcome after head injury compared with individuals without an APOE4 allele, as assessed using the Glasgow outcome scale (Teasdale et a!., 1997) . Two reports also have documented an asso ciation between the E4 isoform and poor prognosis after closed head injury (Sorbi et a!., 1996; Seliger et aI., 1997) . In a preliminary study of boxers, possession of APOE4 allele was associated with chronic traumatic brain injury in high-exposure boxers (Jordan et a!., 1997) , further supporting role for apoE genotype on de termining outcome after brain injury.
There are also preliminary clinical data that apoE ge notype affects prognosis after intracerebral hemorrhage. In a recent study, Alberts and others performed genotyp ing on a consecutively ascertained, prospective series of patients with nonaneurysmal intracerebral hemorrhage. Although there was no clear association between apoE genotype and incidence of intracranial hemorrhage, pa-J Cereb Blood Flow Metab, Vol. 18, No.5, 1998 tients with the APOE4 allele had a much higher mortality than those with the more common apoE genotypes E21E3 or E3/E3 (68% versus 19%). Of patients who survived their hemorrhage, those without the APOE4 allele had improved functional recovery (Alberts et aI., 1996) . Thus, although there is conflicting evidence concerning the effect of apoE on risk of intracerebral hemorrhage, recovery appears to be strongly related to apoE genotype (Greenberg et a!., 1996; Nicoll et a!., 1996) .
Additional evidence that apoE genotype is relevant to acute brain injury is taken from patients undergoing car diopulmonary bypass for cardiac surgery procedures. Neuropsychiatric changes occur in as many as 50% to 60% of these patients (Borowicz et aI., 1996; Brugge mans et a!., 1995) . In a recent study, a significant asso ciation was found between apoE4 dose and postoperative cognitive deficits, as measured by a battery of neuropsy chiatric tests (Tardiff et a!., 1997; Newman et a!., 1995) . This observation also supports the contention that apoE either modifies risk of CNS injury or reparative re sponses after acute CNS insult.
Several studies have produced conflicting results re garding the association between apoE genotype and in cidence of thromboembolic stroke (Basun et a!., 1996; Kuusisto et a!., 1995; Couderc et aI., 1993) . In a large, retrospective study examining elderly men, Basun and colleagues found no association between stroke inci dence and apoE genotype (Basun et aI., 1996; Pedro Botet et a!., 1992). However, a reduced frequency of E3/E4 was observed in patients who had survived a prior stroke, which is consistent with the hypothesis that al though apoE genotype may not alter risk for stroke, it may alter recovery once it occurs. The hypothesis that apoE influences recovery from acute CNS injury in an isoform-specific fashion also is consistent with the recent observation that patients with the APOE4 allele are more likely to be cognitively impaired after stroke (Slooter et a!., 1997; Snowden et a!., 1997).
APOLIPOPROTEIN E LOCALIZATION WITHIN THE CNS
In rodents, apoE immunoreactivity is largely confined to astrocytes, although small extracellular deposits have been described in the perivascular and periarachnoid spaces (Boyles et a!., 1985) . Neuronal apoE immunore activity has not been reported in normal rodent brains. However, alterations in the cellular localization of apoE occurs after acute brain injury in rodents (Hall et a!., 1995; Kida et a!., 1995; Horsburgh and Nicoll, 1996a,b; Horsburgh et al. 1997 c) . Most notably, apoE immunore activity is detected in neurons after different forms of ischemic injury, although the appearance of intraneuro nal apoE seems to be dependent on the type and severity of the ischemic insult. In a rat model of cardiac arrest, neuronal apoE is observed at 6 hours after global isch emia (Kida et aI., 1995) , whereas in a transient ischemia model, neuronal apoE is not detected until at least 24 hours after the initial insult (Horsburgh and Nicoll, 1996b) . In general, apoE immunoreactivity after tran sient global ischemia is localized to selectively vulner able brain regions such as the caudate and CA 1 region of A hippocampus (Horsburgh et ai. 1996b ). After injury, apoE immunoreactivity is initially increased in astro cytes and neuropil (preceding neuronal degeneration) and later increases in neurons and processes that are degenerating (Fig. I) . These temporal alterations in the localization and levels of apoE are consistent with an upregulation of apoE by astrocytes, release into the ex- tracellular space, and subsequent uptake by neurons. It is also consistent with a slower rate of upregulation of neu ronal expression from a low baseline. Intraneuronal ac cumulation of apoE also has been reported in a rat model of subdural hematoma within 30 minutes of the initial injury (Horsburgh et aI., 1997c) . The significance of apoE accumulation in injured neurons is unknown, al though it has been speculated that it may be an initial protective response to injury by providing cholesterol and lipids for neuronal repair.
Although rodent models of acute brain injury have been instrumental in providing fundamental information regarding the response of apoE to eNS injury, they do not permit the effect of genotype to be studied (only one apoE isoform has been identified in rat and mouse and is most analogous to the human E4 protein) (Rajavashisth et aI., 1985) . This obviously is crucial in trying to un derstand the role of apoE in human disease.
In humans, apoE is produced primarily by astrocytes. In contrast to healthy rodent brain, where neuronal im munoreactivity is not normally observed, several studies demonstrate that neuronal apoE is present both in pa tients with chronic neurologic disease and normal aged controls (Han et aI., 1994a,b; Benzing and Mufson, 1995) . We also have observed apoE immunoreactivity in young neurologically normal individuals (Horsburgh 1997, unpublished observations) . It remains to be de fined whether apoE genotype is associated with extent of neuronal apoE.
Paralleling the rodent models, human intraneuronal apoE is increased after brain injury. In a preliminary study, we demonstrated marked increases in neuronal apoE immunoreactivity in areas showing acute neuronal injury after global ischemia, hypoglycemia, and status epilepticus (Nicoll et aI., 1997) . Recently, in a cohort of patients who sustained a period of global ischemia as a result of cardiac arrest, apoE immunoreactivity was shown to be significantly increased in hippocampal py ramidal neurons compared with neurologically normal controls (Fig. 2) (Horsburgh et aI., 1997a) . Neuronal apoE is most likely internalized from the extracellular space, since apoE has been demonstrated to be internal ized by neurites in vitro, and astrocytes, but not neurons, have been demonstrated to produce their own apoE mRNA (Poirer et aI., 1993; Poirer et aI., 1991) . Studies are underway in transgenic animals that express neuronal apoE to determine the genotype effect, if any, on the pathologic mechanism and apoE response after ischemic injury (Xu et aI., 1996) .
APOLIPOPROTEIN E MODIFIES OUTCOME AFTER CNS INJURY
Despite the provocative clinical observations suggest ing a role for apoE in the recovery from acute eNS J Cereb Blood Flow Metab. Vol. 18, No. 5, 1998 insult, there have been relatively few animal models sys tematically examining this issue. After entorhinal cortex lesions, the ability of synapses to regenerate is retarded in apoE-deficient mice (Masliah et aI., 1996) . Intracere bral injection of apoE has been reported to partially re store synaptic repair in apoE mice (Masliah et aI., 1997) . These findings suggests that apoE may play an important role in the maintenance and regeneration of synapses. We also have examined the role of apoE in modifying outcome in a murine stroke model. When subjected to focal ischemia and reperfusion, apoE-deficient mice have significantly larger infarct volumes than age-and sex-matched controls (Fig. 3) (Peidrahita et aI., 1992; Laskowitz et aI., 1997b) . We also have data showing apoE-deficient mice have significantly increased neuro nal damage after an episode of global ischemia compared to wild-type littermate controls (Horsburgh et aI., 1998, unpublished observations) .
Of significance has been the recent development of transgenic mice that express the human E3 and E4 iso forms (but not their native murine apoE) (Xu et aI., 1996) . These mice express comparable amounts of apoE appropriately in glia and other tissue, and serum choles terol is corrected, suggesting the presence of functional apoE protein. Moreover, these mice, which are bred us ing human genomic DNA, provide a model of "human ized" apoE expression, since the apoE gene is under the control of a human promoter and a primate pattern of neuronal immunoreactivity is observed (Xu et aI., 1996) . When subjected to transient focal ischemia and reperfu sion, mice expressing the E4 isoform had significantly larger infarct volumes than mice expressing the E3 iso form (Sheng et aI., 1998) . This is the first animal model to address isoform-specific effects in acute eNS injury, and is consistent with clinical data suggesting that apoE might influence eNS recovery in an isoform-specific fashion. 
APOLIPOPROTEIN E AND THE CNS RESPONSE TO INJURY
Evidence supports the contention that apoE may pro tect against oxidative injury, modulate glial activation, or have direct and indirect neurotropic properties. These mechanisms of action are not mutually exclusive, and it is certainly possible that apoE modulates the CNS re sponse to injury at several functional levels.
One possible explanation for the effects of apoE in the CNS is that it protects against oxidative insult and the ensuing process of lipid peroxidation. This is consistent with recent observations that apoE has the ability to pro tect a neuronal cell line from hydrogen peroxide toxicity in isoform-specific fashion (E2 > E3 > E4) (Miyata and Smith, 1996) . The possibility that apoE protects against oxidative injury also is consistent with observations that plasma lipoproteins from apoE-deficient mice are more susceptible to in vitro oxidation than those of wild-type mice, and that apoE-deficient animals express higher ti ters of autoantibodies directed against oxidized lipids than control animals (Palinski et ai., 1994; Hayek et ai., 1994) . Brains from apoE-deficient animals also have in creased levels of 3-nitrotyrosine, a marker of protein ni tration by peroxynitrite, as compared with controls (Mat thews and Beai., 1996) . All of these results suggest that apoE may play a role in modulating oxidative stress. Presumably, apoE either could act directly as a free radi cal scavenger, or sequester peroxidized lipids to prevent the propagation of lipid peroxidation.
Another potential mechanism by which apoE may ex ert its protective effects is by modulating the glial re sponse to inflammation. Apolipoprotein E is known to have immunomodulatory effects in vitro, which include suppression of lymphocyte proliferation and immuno globulin synthesis after mitogenic stimulation (Pepe and Curtiss, 1986; Macy et aI., 1983; Avila et aI., 1982; Cur tiss and Edgington, 1981; Edgington and Curtiss, 198 1; Hui et ai., 1980; Curtis and Edgington, 1978) . In our laboratory, we have examined the possibility that apoE, which is the primary apolipoprotein produced within the CNS, may modulate the CNS inflammatory response as well. We have demonstrated that apoE suppresses glial secretion of inflammatory cytokines in a specific and dose-dependent fashion (Laskowitz et aI., 1997a) . We also have observed that apoE inhibits microglial synthe sis of nitric oxide and inflammatory cytokines in an iso form-specific fashion (Laskowitz and others, unpub lished data). These results are consistent with the obser vation that apoE modulates microglial activation after exposure to secreted amyloid precursor protein in an iso form-specific manner (Barger and Harmon, 1997). Thus, it is possible that apoE suppresses microglial activation and subsequent release of cytotoxins associated with acute CNS injury. There is increasing evidence that in flammation may contribute to the pathogenesis of chronic neurodegenerative diseases such as Alzheimer's disease, and also may exacerbate secondary neuronal in jury after acute CNS insult (Arvin et aI., 1996; Rogers et aI., 1996; Aisen, 1996; Garcia et aI., 1994) . Thus, if apoE modulated the CNS inflammatory response in an iso form-specific fashion, it might play an important role in both acute and chronic CNS disease.
A third possible mechanism by which apoE might al ter recovery in neurologic disease is through a direct neurotrophic effect on injured neurons. This is consistent with apoE-enhanced survival of a neuronal cell line after exposure to hydrogen peroxide, and also with observa tions that apoE promotes neurite outgrowth in an iso form-specific fashion (Miyata and Smith, 1996; Bellosta, et aI., 1995; Holzman et aI., 1995; Nathan et aI., 1994) . In addition to its direct neurotrophic effects, apoE has been demonstrated to bind to and potentiate the neuro trophic effects of growth factors such as ciliary neuro trophic factor (Gutman et aI., 1997) . Similarly, apoE binds to components of the extracellular matrix, such as laminin, to enhance neuronal adhesion and growth (Huang et ai., 1995) .
CONCLUSION
In summary, there is increasing evidence that apoE is a biologically important mediator of the CNS response to injury, and that a differential effect may exist between apoE isoforms. Following the original association be tween the APOE4 allele and increased risk of developing sporadic and late-onset familial Alzheimer's disease, re cent clinical observations support the possibility that apoE may play an isoform-specific role in recovery from acute CNS insult as well. The development of apoE deficient mice and transgenic animal models designed to express the human apoE isoforms no doubt will facilitate our understanding of the normal biological role of apoE in vivo. Although the mechanisms by which apoE influ ences risk of Alzheimer's disease and recovery after acute CNS insult remains to be defined, it is likely that apoE's role in the CNS is not limited to lipid transport. A better understanding of the neurobiology of apoE prom ises to provide new insights into our understanding of the CNS responses to acute and chronic injury (Roses, 1995) .
